512101 — Triochem Products Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Triochem Products, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 200 | 139 | 88.2 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 64.2 | 13.3 | 25.2 | 0 | -0.001 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 157 | 145 | 76 | 14.5 | 23 |
Operating Profit | 43.2 | -6.06 | 12.2 | -14.5 | -23 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 45.5 | -5.81 | 17.6 | -11.7 | -13.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 34 | -4.47 | 13.2 | -8.85 | -10.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 34 | -4.47 | 13.2 | -8.85 | -10.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 34 | -4.47 | 13.2 | -8.85 | -10.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 139 | -18.2 | 54.2 | -36.1 | -10.7 |